Evidence map›Paper›PMID 38993757›Full record

ArticleFrontiers in transplantation2024

Case Report: Post-transplant lymphoproliferative disorder as a serious complication of vascularized composite allotransplantation.

Alessandra Zaccardelli, Fabienne M Lucas, Ann S LaCasce, Anil K Chandraker, Jamil R Azzi, Simon G Talbot

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Posttransplant lymphoproliferative disorder after uterus transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alessandra ZaccardelliDepartment of Medical Education, Tufts University School of Medicine, Boston, MA, United States.
Fabienne M LucasDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, United States.
Ann S LaCasceDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Anil K ChandrakerDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
Jamil R AzziDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
Simon G TalbotDivision of Plastic and Reconstructive Surgery, Brigham and Women's Hospital, Boston, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascularized composite allotransplantation (VCA) is an emerging field in transplant surgery. Despite overall positive outcomes, VCA confers risk for multiple complications related to the procedure and subsequent immunosuppression. Post-transplant lymphoproliferative disorder (PTLD) is a heterogeneous group of lymphoproliferative disorders occurring after solid organ and hematopoietic stem cell transplant. A patient with PTLD after bilateral upper extremity transplantation is presented as well as a review of all known cases of PTLD after VCA, with a focus on the unique epidemiology, presentation, and treatment in this population.

Indexed as

histopathology diffuse large B-cell lymphomaimmunosuppressionpost-transplant lymphoproliferative disorderrejectionvascularized composite allotransplantation

Identifiers

PMID38993757
PMCPMC11235340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.